Moneycontrol PRO
Live Now |Traders Carnival 15th Edition - 3 days 12 sessions Virtual Event brought to you by Moneycontrol Pro
you are here: HomeNewscoronavirus

Novel coronavirus may infect a higher proportion of pregnant women: ICMR study

According to the study published in the Indian Journal of Medical Research, the most common complication were a pre-term delivery and hypertensive disorders in pregnancy.

September 16, 2021 / 08:56 PM IST
Representative Image

Representative Image

The novel coronavirus may infect a higher proportion of pregnant women and they can develop moderate-to-severe diseases, an ICMR study has said, underlining the need for them to seek immediate medical attention.

According to the study published in the Indian Journal of Medical Research, the most common complication were a pre-term delivery and hypertensive disorders in pregnancy.

Comorbidities such as anaemia, tuberculosis and diabetes mellitus were associated with an increased risk of maternal death in pregnant and post-partum women with COVID-19, the study said.

It analysed clinical characteristics and pregnancy outcomes of women with COVID-19 enrolled during the first wave of the pandemic in Maharashtra.

The analysis was based on the data from the PregCovid registry, a study of pregnant women and women in post-partum period with confirmed diagnosis of COVID-19.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The PregCovid registry collected information on near-real time basis on pregnant and post-partum women with a laboratory-confirmed coronavirus infection from 19 medical colleges across Maharashtra.

The data of 4,203 pregnant women collected during the first wave (March 2020-January 2021) was analysed.

"There were 3213 live births, 77 miscarriages and 834 undelivered pregnancies. The proportion of pregnancy/foetal loss including stillbirths was six per cent. Five hundred and thirty-four women (13%) were symptomatic, of which 382 (72%) had mild, 112 (21%) had moderate, and 40 (7.5 %) had severe disease.

“The most common complication was preterm delivery (528, 16.3%) and hypertensive disorders in pregnancy (328, 10.1%). A total of 158 (3.8%) pregnant and post-partum women required intensive care, of which 152 (96%) were due to COVID-19 related complications," the findings of the study stated.

The overall case fatality rate (CFR) in was 0.8 per cent. Higher CFR was observed in Pune (9/853, 1.1%), Marathwada (4/351, 1.1%) regions as compared to Vidarbha (9/1155, 0.8%), Mumbai Metropolitan (11/1684, 0.7%), and Khandesh (1/160, 0.6%) regions.

"Thus, our analysis suggests that SARS-CoV-2 may infect a higher proportion of pregnant women, and when symptomatic, a large proportion can develop moderate-to-severe diseases. Therefore, pregnant women with COVID-19 need immediate medical attention from the healthcare system in India,” said the study.

The finding of tuberculosis as a risk factor is important as India has one of the highest burden of TB in the general population as well as in pregnant women, the study stated.

It suggested the healthcare services for the treatment of tuberculosis and COVID-19 must be integrated and pregnant women with respiratory symptoms tested for both.

There were a total of 34 deaths reported among pregnant and post-partum women with COVID-19, the study said, adding out of 34 maternal deaths, 10 women died during the post-partum period. Twenty-five women (73%) were 30 or below, while the others were in the age range of 30-45 years.

This is the first large-scale report of systematically collected, multicentre data on the clinical presentation, pregnancy outcomes and maternal deaths amongst women with COVID-19 in Maharashtra, the study said.

"The pre-term birth in the present study group (16.3 per cent) is comparable to those reported by other countries. However, in the absence of detailed data of pre-term birth from pregnant women without COVID-19, it is difficult to comment if COVID-19 is a risk factor for pre-term birth," the study stated.

Pregnancy loss is a major health concern for obstetricians and whether COVID-19 is a contributing risk factor is an important aspect to be considered, it said
first published: Sep 16, 2021 08:56 pm

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark